A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases

Autor: Néboa Zozaya, Maria Iciar Arrizubieta Basterrechea, Elena Bollo, Iván Castellví, Jaime Espín, Norberto Ortego, José Luis Poveda-Andrés, José Antonio Rodríguez Portal, Agustín Rivero, José Antonio Marcos-Rodríguez, Luis Verde

Publikováno v: International journal of technology assessment in health care
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Objectives Our aim was to assess the value of nintedanib for non-idiopathic progressive fibrosing interstitial lung disease (non-IPF PF-ILD) and systemic sclerosis-associated ILD (SSc-ILD) in the Spanish context, using a multi-criteria decision analy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1889fc49fdd742ca493ecee26e961436
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=16757

Effectiveness and safety of eribulin for human epidermal growth factor receptor 2 negative metastatic breast cancer in a real-world population

Autor: Esther Márquez Saavedra, Rocío Jiménez Galán, Rocío Díaz-Acedo, Antonio Gutiérrez Pizarraya, María Rodríguez-de-la-Borbolla-Artacho, Mercedes Galvan Banqueri, Silvia Artacho Criado, José Antonio Marcos Rodríguez

Publikováno v: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 28(7)

Background Eribulin’s clinical benefit remains unclear; so, studies analyzing its effectiveness in routine clinical practice are interesting. Patients and methods This is a multicenter, retrospective study including patients with human epidermal gr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a673d5305a78957c48c3cbbc8142a5b9
https://pubmed.ncbi.nlm.nih.gov/34558360

Recent Advances in the Management of Patients with Non-Muscle-Invasive Bladder Cancer Using a Multidisciplinary Approach: Practical Recommendations from the Spanish Oncology Genitourinary (SOGUG) Working Group

Autor: José Rubio-Briones, Ferran Algaba, Enrique Gallardo, José Antonio Marcos-Rodríguez, Miguel Ángel Climent, on behalf of the SOGUG Multidisciplinary Working Group

Publikováno v: Cancers
Cancers, Vol 13, Iss 4762, p 4762 (2021)

Simple Summary This report presents clinically relevant advances in the management of non-muscle-invasive bladder cancer, which have been the focus of discussion of expert members of the Spanish Oncology Genitourinary (SOGUG) Multidisciplinary Workin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1beeadf12f25061a2a463d7e319c1619
https://doi.org/10.3390/cancers13194762

Libro Blanco de la Carga Socioeconómica del Cáncer de Próstata en España

Autor: Josep Campà Bortolo, José Antonio Marcos Rodríguez, Álvaro Hidalgo Vega, Javier Mar Medina, Néboa Zozaya González, María Dolores Fraga Fuentes, Bleric Alcalá Revilla, María Dolores Alvarado Fernández, Luz María Peña Longobardo, Julio García Comesaña, Juan Oliva Moreno

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7427d8501bd60bb7557903563510a630
https://doi.org/10.37666/l7-2018

[Oral chemotherapy: food-drug interactions]

Autor: Sara Santana Martínez, José Antonio Marcos Rodríguez, Elia Romero Carreño

Publikováno v: Farmacia Hospitalaria v.39 n.4 2015
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Farmacia Hospitalaria, Vol 39, Iss 4, Pp 203-209 (2015)

oral chemotherapy is increasingly used in Oncology. It has important advantages. such as patient comfort. but it also brings new challenges which did not exist with the intravenous therapy. Some of these drugs have interactions with food. leading to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ae44e3f871283ecba35dbec7bbdef112
https://pubmed.ncbi.nlm.nih.gov/26276738